Felix Zintl

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

Christian Urban, Martin Zimmermann, Martin Stanulla, 2007, Blood.

Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure

Raymonda Varon, H. Hoehn, D. Schindler, 2007, Orphanet journal of rare diseases.